New Prefillable Syringe Nest Design from SCHOTT Pharma

SCHOTT Increases Syringe Nest Capacity by 60%

Pharmaceutical manufacturers the world over are facing increased regulatory pressure to ensure the highest levels of cleanliness, sterility and particle control. The use of pre-sterilised RTU containment solutions has helped to ease this burden, and pharmaceutical packaging manufacturers have been stepping up to offer practical solutions suitable for high-speed, large-scale drug production.

RTU containers are often supplied in a nest format, which supports automated filling on both small and large aseptic filling and capping machinery. These pre-sterilised components mitigate risk for the manufacturer and offer a reduction in processing costs.

Read our article on the implications of Annex 1 updates

Pharmaceutical packaging giant, SCHOTT Pharma, has developed a new nest design for their RTU TOPPAC® polymer syringe range. The new design maintains the same nest dimensions while holding 160 syringes, which is a staggering 60% increase on the standard nest.

The new design will allow pharma companies to increase their efficiency by as much as 67% significantly reducing manufacturing costs and reducing carbon footprint by 17%. In addition to reducing direct costs, further savings are achieved by minimising transportation requirements, storage space, and ready-to-use waste.

By collaborating with Bausch+Ströbel, SCHOTT have created an RTU syringe nest which is fully compatible with their high-speed filling lines, requiring only minor retrofit changes to existing lines.

Talk to our team today to discuss your requirements: Contact Us.

Adelphi has been a proud agent, stockist and distributor for SCHOTT Pharma since 1985.